aurintricarboxylic acid has been researched along with mocetinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budde, JM; Guyton, RA; Morris, CD; Muraki, S; Sun, HY; Wang, NP; Zhao, ZQ | 1 |
1 other study(ies) available for aurintricarboxylic acid and mocetinostat
Article | Year |
---|---|
Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Apoptosis; Aurintricarboxylic Acid; bcl-2-Associated X Protein; Biomarkers; Blotting, Western; Caspase 3; Caspases; Creatine Kinase; DNA Fragmentation; Dogs; Endonucleases; Female; In Situ Nick-End Labeling; Male; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Peroxidase; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Vasodilator Agents | 2003 |